enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
enGene Holdings Inc. (Nasdaq: ENGN, enGene or the Company), a clinical-stage, non-viral genetic medicines company, today announced that it has entered into an amendment to an amended and restated...